Mahamaya Lifesciences IPO GMP Today
The Mahamaya Lifesciences IPO GMP is ₹0 (0.0% over the upper price band of ₹114) as of 7 Oct 2026, giving an estimated listing price of ₹114 per share. On a minimum application of 2,400 shares, that is an estimated gain of ₹0.
Last updated
- Issue Price
- ₹114
- GMP
- ₹0
- GMP %
- 0.0%
- Est. listing
- ₹114
- Est. gain / application
- ₹0
Mahamaya Lifesciences IPO GMP trend
Mahamaya Lifesciences IPO GMP day-wise
No grey market activity has been reported for Mahamaya Lifesciences IPO yet. GMP usually starts trading a few days before the issue opens.
Mahamaya Lifesciences IPO subscription status
| QIB | 1.19x |
|---|---|
| Retail | 1.02x |
| Total | 1.71x |
Reading the Mahamaya Lifesciences IPO GMP
The grey market premium is the price above the issue price at which Mahamaya Lifesciences IPO shares are informally traded before listing. A GMP of ₹0 on an upper band of ₹114 suggests the shares could open around ₹114, if grey market sentiment holds until listing day.
GMP is not set by the company, the exchanges or SEBI. It moves daily with market conditions and subscription demand, and SME GMP in particular can swing sharply on low volumes. Check it together with the subscription numbers and the company's financials before applying.
A zero GMP means grey market participants currently expect little or no premium on listing.
Mahamaya Lifesciences IPO GMP: FAQs
- What is Mahamaya Lifesciences IPO GMP today?
- The latest grey market premium (GMP) for the Mahamaya Lifesciences IPO is ₹0 as of 7 October 2026, which is 0.00% over the upper price band of ₹114.
- What is the expected listing price of Mahamaya Lifesciences IPO?
- Based on the current GMP, the estimated listing price of Mahamaya Lifesciences IPO is ₹114 per share (₹114 issue price + ₹0 GMP). This is an estimate from unofficial grey market trades, not a guaranteed listing price.
- What is the lot size and minimum investment for Mahamaya Lifesciences IPO?
- The lot size is 1,200 shares. The minimum application is 2 lots (2,400 shares), which costs ₹2,73,600 at the upper price band.
- Is IPO GMP reliable?
- GMP reflects unofficial trades before listing and changes daily with market mood and subscription demand. It is a useful sentiment indicator but often differs from the actual listing price, so use it alongside the company's financials and subscription data.
GMP is an unofficial indicator compiled from grey market sources and is not investment advice. Actual listing prices can differ significantly. Read the offer document before investing.